Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions – Fifth Meeting
National Academies of Sciences 2101 Constitution Ave NW, Washington, DC, United StatesIn response to a Congressional request, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine is conducting a study on processes for evaluating the safety and